Quanhecheng completed 28 million A+ round of financing
Quanhecheng is a small molecule drug and IVD raw material CDMO platform, mainly engaged in drug molecular building blocks, drug intermediates, liquid crystal material monomers, process optimization, pilot and production services, as well as project process development technical services. Recently, Quanhecheng completed the 28 million A+ round of financing. The investors are Binhai Venture Capital, […]
Quanhecheng completed 28 million A+ round of financing Read More »